Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 06/30/26
2 Beaten-Down Artificial Intelligence (AI) Stocks for Contrarian Investors to Consider BuyingThe Motley Fool • 06/26/26
Recursion Pharmaceuticals (RXRX) Ascends While Market Falls: Some Facts to NoteZacks Investment Research • 06/24/26
Recursion Pharmaceuticals: Short-Trade Crowded But Near-Term Squeeze Not GuaranteedSeeking Alpha • 06/12/26
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should KnowZacks Investment Research • 06/10/26
Recursion Pharmaceuticals, Inc. (RXRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/09/26
Recursion Pharmaceuticals (RXRX) Up 16.2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/05/26
Altitude Lab Portfolio Companies Surpass $205 Million in Funding, Marking a New Era for Early-Stage Biotechs in Salt Lake CityGlobeNewsWire • 05/19/26
Recursion Pharmaceuticals, Inc. (RXRX) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/12/26
Recursion Eyes Breakthrough With REC-4881 Drug For Rare Genetic Condition, But Shares Pull BackBenzinga • 05/07/26
Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/06/26
Recursion Reports First Quarter Financial Results and Provides Business UpdateGlobeNewsWire • 05/06/26
Recursion Pharmaceuticals (RXRX) Stock Dips While Market Gains: Key FactsZacks Investment Research • 05/01/26
Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6GlobeNewsWire • 04/29/26
Recursion Pharmaceuticals, Inc. (RXRX) Presents at 25th Annual Needham Virtual Healthcare Conference TranscriptSeeking Alpha • 04/17/26
Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to NoteZacks Investment Research • 04/16/26
Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to KnowZacks Investment Research • 04/02/26
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech PlatformGlobeNewsWire • 03/31/26